These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance]. Nakamura T Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380 [No Abstract] [Full Text] [Related]
8. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R Obes Res; 2002 Nov; 10(11):1095-103. PubMed ID: 12429872 [TBL] [Abstract][Full Text] [Related]
9. A transgenic model of visceral obesity and the metabolic syndrome. Masuzaki H; Paterson J; Shinyama H; Morton NM; Mullins JJ; Seckl JR; Flier JS Science; 2001 Dec; 294(5549):2166-70. PubMed ID: 11739957 [TBL] [Abstract][Full Text] [Related]
10. Thermodynamics, liposuction, and metabolism. Kelley DE N Engl J Med; 2004 Jun; 350(25):2542-4. PubMed ID: 15201408 [No Abstract] [Full Text] [Related]
11. Growth hormone--ready for prime time? Marcus R; Reaven GM J Clin Endocrinol Metab; 1997 Mar; 82(3):725-6. PubMed ID: 9062472 [No Abstract] [Full Text] [Related]
12. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870 [TBL] [Abstract][Full Text] [Related]
13. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)]. Kochan Z; Karbowska J Przegl Lek; 2003; 60(1):40-2. PubMed ID: 12884646 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein metabolism in visceral obesity. Després JP Int J Obes; 1991 Sep; 15 Suppl 2():45-52. PubMed ID: 1794938 [No Abstract] [Full Text] [Related]
15. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance. Korach-André M; Gao J; Gounarides JS; Deacon R; Islam A; Laurent D Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E106-16. PubMed ID: 15328072 [TBL] [Abstract][Full Text] [Related]
16. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542 [No Abstract] [Full Text] [Related]